Dupixent for Eosinophilic Esophagitis (EoE) Accepted for Priority Review
According to a recent article from WFMZ+, the FDA has recently approved Regeneron's supplemental Biologics License Application (sBLA) for Dupixent, granting it priority review. Dupixent, also known by the generic…